Monday News
PRA Expands In Mexico City
Bulletins on Pharm-Olam, Kika, breast cancer award, PRA, medical ghostwriting, ACRP and the Shanghai Clinical Research Center.
At the Drug Information Association’s (DIA) 43rd Annual Meeting, June 17–21, 2007, in Atlanta, GA, experts from Parexel International, a major contract research organization, will present key topics. Dr. Alberto Grignolo, PhD, corporate vice president and general manager of drug development consulting for Parexel and the DIA annual meeting chairperson,…more...
North Carolina’s etrials announced that existing customers had awarded it four new projects worth $1.7 million. The upcoming projects cover almost 300 sites across North and South America as well as in Europe, and will include over 3,500 individual subjects. The trials will deploy etrials’ eDiary, EDC and IVR solutions…more...
Experts from Phoenix Data Systems, a Pennsylvania-based electronic data capture company, have been chosen to present multiple sessions at the 43rd Annual Drug Information Association (DIA) Meeting in Atlanta, Georgia, from June 17-21, 2007. Phoenix Data Systems’ (PDS) presentations include hot subjects such as functional outsourcing and adaptive trials. In…more...
Pacific Edge Biotechnology (PEB) announces that it has signed a collaborative research agreement with the international Ludwig Institute for Cancer Research. PEB, an Otago University start-up, said it was developing a number of novel tools and methods for the early detection and management of cancer. The agreement follows promising early…more...
inVentiv Health selected ClinPhone EDC for its trials. Under the arrangement, inVentiv will transfer the technology in-house. Mike Hlinak, president and CEO of inVentiv Clinical Solutions said: “This agreement with ClinPhone allows us to further broaden our service offering by adding our own EDC system which will no doubt better…more...
Clinical trial technology suite Phase Forward has renewed its alliance with Parexel, a contract research organization. The multi-year agreement allows Parexel to continue to offer Phase Forward’s InForm electronic data capture (EDC) product as an integral part of its solution set. A Phase Forward alliance partner since 1999, Parexel provides…more...
A Thomson Centerwatch poll of clinical sites found that Kendle International is the highest-rated contract research organization (CRO). Kendle was rated a top-three CRO on 26 of the 29 individual survey attributes—more times than any other CRO included in the survey and 63% more frequently than the next highest CRO.…more...
PharmaVoice and TNS Media Intelligence are sponsoring a free webinar on marketing in the age of anti-industry publicity. The session is on June 20th, 2007 at 2:00 p.m. Eastern. Titled “Surviving the Election Wars: Strategies to Build Trust and Protect Brands,” the webinar promises tips on using direct-to-consumer ads and…more...
Mission3, an Arizona-based provider of pharmaceutical project, document, and submission management software, announced that it continues its drive for good informatics practices through its partnership with LSIT Global Institute. LSIT has published an article by Dirk Karsten Beth, president of Mission3. Writes Beth: “The eCTD submission [electronic common technical document]…more...
Specialty pharma Cobalis will delay reporting trial results because of concerns about the quality of data from electronic patient diaries. Cobalis’s two similar Phase III allergy trials had a total of 1,551 patients and 23 sites. Here’s a quote from the press release: “Given inconsistencies it has identified, the company…more...
January 8, 2009
Bulletins on Pharm-Olam, Kika, breast cancer award, PRA, medical ghostwriting, ACRP and the Shanghai Clinical Research Center.
Bulletins on Icon, Isis, AAALAC, MDS Pharma, DataTrak, Pantheon, and PhaseForward.
Bulletins on MDS, Cmed, Roche, Bio-Imaging, AG Mednet, Decision View and Thermo Fisher Scientific.
Bulletins on Parexel, SITS, Cortia, asthma, SeraCare, PDL Biotech and the Clinical Trials Congress.
Bulletins on ThotWave, CDISC, FDA, AstraZeneca, APP Pharmaceuticals, Velos, University of Kansas, VirtualScopics and ISSCR.
Bulletins on Decision View, OpSource DIA, PRA, FDA, WebMD, Phase Forward and Pfizer UK.
Organizations
Conferences
Info & Opinion